Zambia: Can a Herbal Preparation Called SF2000 Cure Aids?
[Africa Check] For years Zambian lawyer and politician Ludwig Sondashi has been saying that his Sondashi Formula 2000 preparation kills HIV, the virus that causes AIDS. But it has never been proven.
Condition: Hearing Loss Interventions: Device: Mermaid 9 ITE; Device: Mermaid 9 BTE Sponsor: Bernafon AG Completed
Condition: HIV/AIDS Interventions: Behavioral: WISH Adherence; Behavioral: WISH Parenting Sponsor: University of Pennsylvania Not yet recruiting
ConclusionsTherefore, we infer that serum miRNAs in HIV-1 infection may play important roles in HIV-induced cancer and could be used as a potential biomarker for HIV-cancers detection.
[Citizen] Kampala -Marie Stopes Uganda has been directed to recall two batches of Life Guard brand condoms from the Ugandan market following customers' complaints.
How might ART regimens including inhibitors of the tubular secretion of creatinine impact kidney function in HIV patients?HIV Medicine
[Monitor] Marie Stopes Uganda, a non-government organisation that offers reproductive health services, has been directed to recall two batches of Life Guard brand condoms from the Ugandan market following customers' complaints.
CONCLUSIONS: If there is a causal association between DMPA use and HIV risk, it could have substantially increased the scale of the HIV epidemic in South Africa, affecting not only the users of DMPA, but also their partners and the wider population. The magnitude of this potential effect demands careful data collection and a careful consideration of policy choices for contraception in settings with large HIV epidemics. PMID: 31729195 [PubMed - in process]
CONCLUSIONS: The prevalence of HIV among transgender women in our study, at 14.8%, is among the highest detected in any population in eastern China. Chinese transgender women may therefore follow the disparity in the burden of HIV noted worldwide. Data support policies to prioritize transgender women for HIV testing outreach, for in-depth research to better understand the specific drivers of infection in this population, and for trans-friendly HIV care and prevention programmes to address their specific needs. PMID: 31729178 [PubMed - in process]
Government officials say the objective is to encourage competition and reduce costs